查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1947429

週邊血管器械市場：依類型[血管成形球囊、支架、導管（導引導管、血管內超音波導管）、下腔靜脈濾器、斑塊切除術、血栓切除術、血流控制（栓塞預防、閉塞）]和地區劃分 - 全球預測至 2036 年

Peripheral Vascular Devices Market by Type [Angioplasty Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter, Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic Protection, Occlusion)] and Geography - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 220 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球週邊血管器械市場預計在預測期（2026-2036 年）內將以 7.5% 的複合年增長率增長，從 2026 年的 104.9 億美元增長到 2036 年的約 216 億美元。本報告對五大主要地區的周邊血管器械市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至 2036 年的預測。

基於廣泛的一手和二手研究以及對市場現狀的詳細分析，本報告對關鍵行業驅動因素、限制因素和機會的影響進行了分析。 以及挑戰。推動週邊血管器械市場成長的關鍵因素包括週邊動脈疾病（PAD）盛行率上升、全球人口老化以及微創血管內治療的日益普及。此外，藥物洗脫支架和球囊技術的進步、生物可吸收支架的開發、對複雜病變和膝下疾病治療的關注，以及人們對早期診斷和治療意識的不斷提高，預計將為外周血管器械市場的企業創造巨大的增長機會。

市場區隔

目錄

第一章：引言

第二章：研究方法

第三章：摘要整理

  • 依類型劃分的市場分析依地區劃分的市場分析競爭分析

第四章 市場洞察

  • 市場概覽
  • 驅動因素
    • 人口老化加劇和周邊動脈疾病 (PAD) 的盛行率
    • 微創手術的日益普及
  • 限制因素
    • 先進醫療器材成本高昂
    • 產品故障和召回
  • 機遇
    • 新興市場與未開發的病患群體
    • 技術創新
  • 趨勢
    • 生物可吸收支架及藥物洗脫球囊
    • 關注複雜病變與 BTK 疾病

第五章 全球週邊血管器材市場（依類型劃分）

  • 血管成形球囊
    • 傳統球囊
    • 藥物洗脫球囊（藥物洗脫球囊）
  • 血管成形術支架
    • 藥物洗脫支架 (DES)
    • 裸金屬支架
      • 球囊擴張支架
      • 自擴張支架
  • 導管
    • 血管攝影導管
    • 導引導管
    • 血管內超音波/光學相干斷層掃描導管
  • 血管內動脈瘤修復術 (EVAR) 支架筏
    • 腹部 EVAR 移植物
    • 胸部 EVAR 移植物
  • 下腔靜脈 (IVC) 濾器
    • 可回收濾器
    • 永久性濾網濾網
  • 斑塊改良裝置
    • 動脈粥狀斑塊切除裝置
    • 血栓切除裝置
  • 血流控制裝置
    • 栓塞保護裝置
    • 慢性完全阻塞 (CTO) 治療裝置
  • 其他裝置
    • 血管閉合裝置
    • 人工血管移植

第六章 全球週邊血管裝置市場（依地區劃分）

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他地區歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 亞太其他地區
  • 拉丁美洲
  • 中東和非洲

第七章 競爭格局

  • 市場結構分析（分層供應商格局）
  • 關鍵成長策略
    • 併購
    • 合作與聯盟
    • 產品發布與升級
  • 競爭概覽
  • 供應商市場定位
  • 市佔率分析
  • 策略建議

第8章 企業簡介

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Cook Group
  • Koninklijke Philips N.V.
  • BIOTRONIK SE &Co. KG
  • AngioDynamics, Inc.
  • Teleflex Incorporated
  • OrbusNeich Medical Group Holdings Limited
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Cordis(a Cardinal Health Company)
  • Lake Region Medical Holdings, Inc.
  • Others

第9章 附錄

簡介目錄
Product Code: MRHC - 104486

According to the research report titled, 'Peripheral Vascular Devices Market by Type [Angioplasty Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter, Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic Protection, Occlusion)] and Geography - Global Forecast to 2036,' the global peripheral vascular devices market is expected to reach approximately USD 21.6 billion by 2036 from USD 10.49 billion in 2026, at a CAGR of 7.5% during the forecast period (2026-2036). The report provides an in-depth analysis of the global peripheral vascular devices market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the peripheral vascular devices market include rising prevalence of peripheral artery disease (PAD), aging global population, and increasing adoption of minimally invasive endovascular procedures. Additionally, technological advancements in drug-eluting stents and balloons, development of bioresorbable scaffolds, focus on treating complex lesions and below-the-knee disease, and growing awareness about early diagnosis and treatment are expected to create significant growth opportunities for players operating in the peripheral vascular devices market.

Market Segmentation

The peripheral vascular devices market is segmented by type (angioplasty balloon, stents, catheters, IVC filter, atherectomy, thrombectomy, hemodynamic flow alteration) and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Type

By type, the angioplasty stents segment is expected to account for the largest share of the peripheral vascular devices market in 2026. Stents are the most widely used devices for treating arterial blockages, providing a mechanical scaffold to keep the vessel open and restore blood flow. The development of drug-eluting stents (DES), which release medication to prevent the recurrence of blockages, has further solidified their position as the standard of care. Drug-eluting balloons are projected to grow at the fastest CAGR, driven by their ability to deliver anti-proliferative drugs directly to the vessel wall without requiring permanent stent implants. Other segments include angioplasty balloons, catheters (guiding and IVUS), IVC filters, atherectomy devices, thrombectomy systems, and hemodynamic flow alteration devices.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to dominate the global peripheral vascular devices market with the largest market share in 2026, attributed to high prevalence of peripheral vascular diseases, well-established healthcare system with high rates of diagnosis and treatment, and favorable reimbursement policies for endovascular procedures. Asia-Pacific is projected to witness the fastest growth during the forecast period, driven by large and aging population, rising prevalence of risk factors like diabetes and hypertension, and increasing healthcare investments in countries like China and India.

Key Players

The key players operating in the global peripheral vascular devices market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (BD) (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Koninklijke Philips N.V. (Netherlands), and various other regional and emerging manufacturers, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the peripheral vascular devices market globally?
  • At what rate is the global peripheral vascular devices market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global peripheral vascular devices market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of type are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global peripheral vascular devices market?
  • Who are the major players in the global peripheral vascular devices market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global peripheral vascular devices market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Peripheral Vascular Devices Market Assessment -- by Type

  • Angioplasty Balloon
  • Stents
  • Catheters (Guiding, IVUS)
  • IVC Filter
  • Atherectomy
  • Thrombectomy
  • Hemodynamic Flow Alteration (Embolic Protection, Occlusion)

Peripheral Vascular Devices Market Assessment -- by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Southeast Asia
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
    • 2.3.2. Bottom-Up Approach
    • 2.3.3. Top-Down Approach
    • 2.3.4. Growth Forecast
  • 2.4. Assumptions for the Study

3. Executive Summary

  • 3.1. Overview
  • 3.2. Market Analysis, by Type
  • 3.3. Market Analysis, by Geography
  • 3.4. Competitive Analysis

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Rising Geriatric Population and PAD Prevalence
    • 4.2.2. Increasing Adoption of Minimally Invasive Procedures
  • 4.3. Restraints
    • 4.3.1. High Cost of Advanced Devices
    • 4.3.2. Product Failures and Recalls
  • 4.4. Opportunities
    • 4.4.1. Emerging Markets and Untapped Patient Populations
    • 4.4.2. Technological Innovations
  • 4.5. Trends
    • 4.5.1. Bioresorbable Scaffolds and Drug-Coated Balloons
    • 4.5.2. Focus on Complex Lesions and BTK Disease

5. Global Peripheral Vascular Devices Market, by Type

  • 5.1. Introduction
  • 5.2. Angioplasty Balloons
    • 5.2.1. Old/Normal Balloons
    • 5.2.2. Drug-Eluting Balloons (DEB)
  • 5.3. Angioplasty Stents
    • 5.3.1. Drug-Eluting Stents (DES)
    • 5.3.2. Bare Metal Stents
      • 5.3.2.1. Balloon-Expandable Stents
      • 5.3.2.2. Self-Expandable Stents
  • 5.4. Catheters
    • 5.4.1. Angiography Catheters
    • 5.4.2. Guiding Catheters
    • 5.4.3. IVUS/OCT Catheters
  • 5.5. Endovascular Aneurysm Repair (EVAR) Stent Grafts
    • 5.5.1. Abdominal EVAR Grafts
    • 5.5.2. Thoracic EVAR Grafts
  • 5.6. Inferior Vena Cava (IVC) Filters
    • 5.6.1. Retrievable Filters
    • 5.6.2. Permanent Filters
  • 5.7. Plaque Modification Devices
    • 5.7.1. Atherectomy Devices
    • 5.7.2. Thrombectomy Devices
  • 5.8. Hemodynamic Flow Alteration Devices
    • 5.8.1. Embolic Protection Devices
    • 5.8.2. Chronic Total Occlusion (CTO) Devices
  • 5.9. Other Devices
    • 5.9.1. Vascular Closure Devices
    • 5.9.2. Synthetic Surgical Grafts

6. Global Peripheral Vascular Devices Market, by Geography

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Europe
    • 6.3.1. Germany
    • 6.3.2. France
    • 6.3.3. U.K.
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Rest of Europe
  • 6.4. Asia-Pacific
    • 6.4.1. Japan
    • 6.4.2. China
    • 6.4.3. India
    • 6.4.4. Rest of Asia-Pacific
  • 6.5. Latin America
  • 6.6. Middle East & Africa

7. Competitive Landscape

  • 7.1. Introduction
  • 7.2. Market Structure Analysis (Tiered Vendor Landscape)
  • 7.3. Key Growth Strategies
    • 7.3.1. Mergers & Acquisitions
    • 7.3.2. Partnerships & Collaborations
    • 7.3.3. Product Launches & Upgrades
  • 7.4. Competitive Dashboard
  • 7.5. Vendor Market Positioning
  • 7.6. Market Share Analysis
  • 7.7. Strategic Recommendations

8. Company Profiles

  • 8.1. Medtronic plc
  • 8.2. Boston Scientific Corporation
  • 8.3. Abbott Laboratories
  • 8.4. Terumo Corporation
  • 8.5. B. Braun Melsungen AG
  • 8.6. Becton, Dickinson and Company
  • 8.7. Cardinal Health, Inc.
  • 8.8. Cook Group
  • 8.9. Koninklijke Philips N.V.
  • 8.10. BIOTRONIK SE & Co. KG
  • 8.11. AngioDynamics, Inc.
  • 8.12. Teleflex Incorporated
  • 8.13. OrbusNeich Medical Group Holdings Limited
  • 8.14. Merit Medical Systems, Inc.
  • 8.15. MicroPort Scientific Corporation
  • 8.16. Penumbra, Inc.
  • 8.17. Cordis (a Cardinal Health Company)
  • 8.18. Lake Region Medical Holdings, Inc.
  • 8.19. Others

9. Appendix

  • 9.1. Questionnaire
  • 9.2. Available Customization